Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crane

Showing results (121-130 of 344) with videos related to

Pageof 35
Sort By:
American Journal of Clinical Oncology|March 8, 2013
Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicityMelissa P Mitchell, Mirna Abboud, Cathy Eng, et al.
Seminars in Radiation Oncology|June 7, 2020
Challenges in Reirradiation of Intrahepatic TumorsDawn Owen, Jelena Lukovic, Ali Hosni, et al.
Cell and Tissue Research|February 5, 1999
Differentiation-dependent expression of gelatinase B/matrix metalloproteinase-9 in trophoblast cellsT J Peters, A Albieri, E Bevilacqua, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 1, 2008
Proton radiotherapy for liver tumors: dosimetric advantages over photon plansXiaochun Wang, Sunil Krishnan, Xiaodong Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvementJoseph C Hodges, Prajnan Das, Cathy Eng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2012
Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancerPatrick Kelly, Prajnan Das, Chelsea C Pinnix, et al.
Cancer|March 4, 2020
Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysisLeila T Tchelebi, Eric J Lehrer, Daniel M Trifiletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
Advances in Radiation Oncology|April 24, 2020
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer CenterPaul B Romesser, Abraham J Wu, Andrea Cercek, et al.
Annals of Surgical Oncology|November 15, 2006
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canalJohn T Mullen, Miguel A Rodriguez-Bigas, George J Chang, et al.
Pageof 35

Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
American Journal of Clinical Oncology|March 8, 2013
Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicityMelissa P Mitchell, Mirna Abboud, Cathy Eng, et al.
Seminars in Radiation Oncology|June 7, 2020
Challenges in Reirradiation of Intrahepatic TumorsDawn Owen, Jelena Lukovic, Ali Hosni, et al.
Cell and Tissue Research|February 5, 1999
Differentiation-dependent expression of gelatinase B/matrix metalloproteinase-9 in trophoblast cellsT J Peters, A Albieri, E Bevilacqua, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 1, 2008
Proton radiotherapy for liver tumors: dosimetric advantages over photon plansXiaochun Wang, Sunil Krishnan, Xiaodong Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvementJoseph C Hodges, Prajnan Das, Cathy Eng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2012
Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancerPatrick Kelly, Prajnan Das, Chelsea C Pinnix, et al.
Cancer|March 4, 2020
Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysisLeila T Tchelebi, Eric J Lehrer, Daniel M Trifiletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411Christopher H Crane, Kathryn Winter, William F Regine, et al.
Advances in Radiation Oncology|April 24, 2020
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer CenterPaul B Romesser, Abraham J Wu, Andrea Cercek, et al.
Annals of Surgical Oncology|November 15, 2006
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canalJohn T Mullen, Miguel A Rodriguez-Bigas, George J Chang, et al.
Pageof 35